A Chawla (London, UK) gives an overview of cerebral monitoring options in aortic arch surgery.
A Chawla (London, UK) gives an overview of cerebral monitoring options in aortic arch surgery.
F Herth (Heidelberg, Germany) gives an overview of interventional treatment options in emphysema.
M Hawari (Nottingham, UK) presents a complex case of persistent chylothorax for discussion.
J Cox (St Louis, USA) considers the evidence for ablation in atrial fibrillation treatment, to help inform what the future management might be.
D Royston (London, UK) reviews the history of aprotinin and its licencing.
N Briffa (Shiffield, UK) explains the commissioning process for valve surgery in the English NHS.
B Bridgewater (Manchester, UK) introduces a session on early intervention in mitral valve repair. I Ahmed (Brighton, UK) argues in favour of early intervention. R Rosenhek (Vienna, Austria) prefers a watchful waiting approach. D Adams (New York, UK) discusses the…
D Adams (New York, USA) presents evidence for transcatheter aortic valve implantation (TAVI) from the Pivotal trial of the Medtronic CoreValve.
P-E Falcoz (Strasbourg, France) describes the different types of ECMO available for thoracic patients and considers future developments.
I Ahmed (Brighton, UK) argues in favour of developing minimally invasive mitral valve surgery.
S Livesey (Southampton, UK) argues against the widespread adoption of minimally invasive mitral valve surgery.
DK Harrington (Liverpool, UK) reviews the evidence for different techniques of brain protection in aortic arch surgery.
D Taggart (Oxford, UK) gives a quick overview of the evidence for radial artery conduit patency rates.
S Kalkat (Birmingham, UK) outlines the different types of primary chest wall tumours with discussion of chest wall resection and reconstruction.
S Nair (Newcastle, UK) presents an update on the mini-sternotomy trial for aortic valve replacement.
H Khalil (Birmingham, UK) shows a number of cases requiring chest wall soft tissue cover, using a number of different flaps to achieve this.
C Hamm (Bad Nauheim, Germany) explains the use of fractional flow reserve (FFR) in the assessment of coronary stenoses.
M Bhabra (Wolverhampton, UK) describes the evidence for and techniques used in valve-in-valve transcatheter aortic valve implantation.
M Dalrymple-Hay (Plymouth, UK) describes devices available and their mechanisms of action in atrial fibrillation ablation surgery.
M Morgan (Leicester, UK) discusses assessment and case selection of emphysema patients in a multidisciplinary setting.
M Besser (Cambridge, UK) discusses assessment of the bleeding patient, looking at laboratory and point of care testing, and considering possible interventions.
M Sabetai (London, UK) considers the different cannulation options in aortic arch surgery.
This is a panel and audience discussion on the importance of completeness of myocardial revascularisation, with particular emphasis on the use of fractional flow reserve (FFR).
M Shackcloth (Liverpool, UK) presents a case of emphysema for panel discussion.
The panel discuss various aspects of ablation for lone atrial fibrillation.
J Pepper (London, UK) presents evidence against the use of off-pump coronary bypass surgery.
R Clough (London, UK) reviews the evidence for management strategies in type B aortic dissection and describes her ongoing research in this area.
M S Uva (Lisbon, Portugal) argues in favour of off-pump coronary bypass surgery, reviewing the evidence from randomised controlled trials and meta-analyses.
I Hunt (London, UK) presents a case for interactive audience discussion.
O Dapunt (Oldenburg, Germany) describes the different types of sutureless valves available, with a video demonstration of an Enable valve insertion.
D Van Raemdonck (Leuven, Belgium) reviews the relative benefits of lung volume reduction surgery and lung transplantation in patients with emphysema.
G Bisleri (Brescia, Italy) discusses unilateral thoracoscopic ablation in hybrid atrial fibrillation treatment, with a video demonstration of the surgical technique.
R Page (Liverpool, UK) discusses the management of oesophago-airway fistulae.
G Massard (Strasbourg, France) reviews the management of the pleural space in complex situations.
A Brunelli (Leeds, UK) discusses the benefits of digital drainage systems in thoracic practice.
M La Meir (Maastricht, Netherlands) considers aspects of hybrid approaches to lone atrial fibrillation.
B Bridgewater (Manchester, UK) describes his personal experience of starting and then stopping a minimally invasive mitral programme.
D West (Bristol, UK) gives an overview of the issues involved in planning complex multi-specialty surgery.
N Maskell (Bristol, UK) discusses the medical management of pleural infection, including the possible use of medical thoracoscopy.
This is a panel discussion on the philosophy of mitral valve repair.
A Goodwin (Middlesbrough, UK) gives a detailed description of the manubrium-only approach to minimally invasive aortic valve replacement and explains the set-up of the MAVRIC trial.
J-F Obadia (Lyon, France) describes his minimally invasive mitral valve repair techniques, emphasising setup and how he measures the length of the goretex neochordae.
H Isringhaus (Voelklingen, Germany) describes the use of intra-operative imaging techniques, including DynaCT, to aid resection of pulmonary nodules.
D Taggart (Oxford, UK) reviews the evidence for bilateral internal mammary artery use in coronary bypass surgery.
B Gersak (Ljubljana, Slovenia) describes a convergent (hybrid) procedure via a sub-xiphoid approach for the treatment of permanent atrial fibrillation.
H Vanermen (Brussels, Belgium) discusses SAM and how it can be repaired endoscopically.
P De Coppi (London, UK) explores the potential of stem cells in engineered cartilaginous grafts for tracheal repair.
P Modi (Liverpool, UK) describes how he set up a minimally invasive mitral valve programme in Liverpool.
D Adams (New York, USA) discusses the modern role of the Resect philosophy in mitral valve repair.
M Will (Edinburgh, UK) presents a complex thoracic case for discussion.
D Van Raemdonck (Leuven, Belgium) presents an overview of the current status of tracheal transplantation.
A Yilmaz (Amsterdam, Netherlands) describes his techniques for minimally-invasive mitral valve repair, including a video demonstration.
H Vanermen (Brussels, Belgium) gives an overview of techniques used in mitral valve repair, with emphasis on P2.
G Massard (Strasbourg, France) gives an overview of the management of empyema.
L Van Rensburg (Cambridge, UK) describes several injuries that can occur to the shoulder girdle and how they can be managed.
G Murphy (Leicester, UK) gives an overview of blood management strategies in cardiac surgery.
N Moat (London, UK) argues in favour of a Respect philosophy towards mitral valve repsir.
PS Minhas (London, UK) describes cases where a combined approach is appropriate.
Prof G Laufer (Vienna, Austria) argues in favour of CABG in multivessel disease. P Kolh (Liege, Belgium) considers the case in the context of European guidelines. A discussion follows.
M Castella (Barcelona, Spain) reviews the results of the FAST study, considers reasons for failure and looks at techniques to improve the results of surgical ablation.
F Herth (Heidelberg, Germany) describes the extended use of endobronchial devices for stenoses, airleaks and bronchopleural fistulae.
M Bemelman (Tilburg, Netherlands) gives an overview of the current standing of rib fixation.
S Nashef (Cambridge, UK) summarises the development of atrial fibrillation ablation techniques before explaining the aims of the AMAZE trial.
S Benussi (Milan, Italy) demonstrates the use of newer devices for left atrial appendage occlusion.
A Oo (Liverpool (UK) explains the frozen elephant trunk procedure and the grafts available.
M Sabetai (London, UK) describes the different approaches to cannulation in type A aortic dissection.
J Elefteriades (New Haven, USA) discusses the surgical techniques available for aortic arch replacement.
J Elefteriades (New Haven, USA) describes current surgical techniques in the management of type A aortic dissection.
S Salzberg (Zurich, Switzerland) explains the benefits of surgical left atrial appendage occlusion in the management of atrial fibrillation, demonstrating the differing devices available.
P Taylor (London, UK) discusses hybrid approaches to aortic arch disease and the consequences of extra-anatomic bypasses.
J Dunning (Middlesbrough, UK) looks at the evidence for left atrial appendage closure in the management of atrial fibrillation.
P Dartevelle (Paris, France) describes his approach to complex chest wall resections.
H Safi (Houston, USA) considers the evolving strategies in the management of type B aortic dissection.
D Denning (Manchester, UK) gives an excellent overview of the management of aspergillosis, including indications for surgery.
H Safi (Houston, USA) discusses some of the open and endovascular options available in complex aortic surgery.
D Taggart (Oxford, UK) summarises the debate on the evidence for completeness of myocardial revascularisation.
C Hamm (Bad Nauheim, Germany) reviews the evidence for the benefits of complete revascularisation in percutaneous coronary intervention.
P Kolh (Leige, Belgium) considers the long-term results of arterial revascularisation, the SYNTAX trial and the 2010 European Revascularisation Guidelines.
M O’Neill (London, UK) considers how best to measure the success of ablation therapy for atrial fibrillation.
M Dweck (Edinburgh, UK) presents a case of isoated proximal LAD disease. G Laufer (Vienna, Austria) argues in favour of surgery, while C Hamm (Bad Nauheim, Germany) puts forward the case for PCI. P Kolh (Liege, Belgium) considers how the…
V Zamvar (Edinburgh, UK) describes different techniques for assessing intra-operative graft flow.
P Kolh (Leige, Belgium) assesses the evidence for the importance of completeness of myocardial revascularisation in coronary bypass surgery.
J Dark (Newcastle, UK) describes how a mitral valve service was set up in Newcastle.
A Jeppsson (Goteborg, Sweden) assesses how postoperative bleeding might be predicted and thereby prevented.
D Connelly (Glasgow, UK) reviews the epidemiology of atrial fibrillation with a view to informing the commissioning of services.
B Bridgewater (Manchester, UK) explains how the UK database can be used to inform commissioning of mitral valve services.
W Toff (Leicester, UK) explains the rationale for and design of the UK transcatheter aortic valve implantation (TAVI) trial.
O Wendler (London, UK) describes new devices designed to improve outcomes in surgical TAVI.
C Hamm (Bad Nauheim, Germany) gives a brief assessment of off pump surgery from a cardiologist’s viewpoint.
S Ray (Manchester, UK) argues for the development of valve centres of excellence, based on the recommendations in guidelines.
This is a panel discussion following presentations on the use of ablation procedures in the treatment of atrial fibrillation.
S Kalkat (Birmingham, UK) presents a case of bloody pleural effusion with chest wall mass. P McElnay (Bristol, UK) follows with a case involving a large mediastinal mass.
This is a panel discussion following a state of the art mitral valve surgery session.
H Vanermen (Brussels, Belgium) describes the principles of minimally-invasive mitral valve repair for bi-leaflet prolapse, before giving video demonstrations of his techniques.
D Taggart (Oxford, UK) leads an audience discussion on the merits of off-pump coronary bypass surgery.
S Grant (Manchester, UK) presents data from the UK valve and TAVI registries.